QVT Associates GP LLC Insider Trading Transactions
Get free email notifications about insider trading for QVT Associates GP LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of QVT Associates GP LLC. QVT Associates GP LLC is 10% Owner in MEDIVATION, INC. ($MDVN) and 10% Owner in ANADYS PHARMACEUTICALS INC ($ANDS) and 10% Owner in INHIBITEX, INC. ($INHX) and 10% Owner in ACHILLION PHARMACEUTICALS INC ($ACHN) and 10% Owner in Pharmasset Inc ($VRUS) and Director in Arbutus Biopharma Corp ($TKMR) and 10% Owner in TPC Group Inc. ($TXPI) and 10% Owner in Axovant Sciences Ltd. ($AXON) and 10% Owner in Myovant Sciences Ltd. ($MYOV) and Director in Myovant Sciences Ltd. ($MYOV) and 10% Owner in Urovant Sciences Ltd. ($UROV).
Latest Insider Trading Transactions of QVT Associates GP LLC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ACHN, ANDS, TKMR, INHX, MDVN, MYOV, VRUS, AXON, TXPI, UROV
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 19 2019 | UROV | Urovant Sciences L ... | QVT Associates GP LLC | 10% Owner | Buy | P | 8.17 | 4,957 | 40,495 | 22,860,013 | 22.9 M to 22.9 M (+0.02 %) |
Jun 19 2019 | UROV | Urovant Sciences L ... | QVT Associates GP LLC | 10% Owner | Buy | P | 8.21 | 6,706 | 55,061 | 22,855,056 | 22.8 M to 22.9 M (+0.03 %) |
Jun 19 2019 | UROV | Urovant Sciences L ... | QVT Associates GP LLC | 10% Owner | Buy | P | 8.53 | 6,541 | 55,825 | 22,848,350 | 22.8 M to 22.8 M (+0.03 %) |
Jun 14 2019 | UROV | Urovant Sciences L ... | QVT Associates GP LLC | 10% Owner | Buy | P | 7.91 | 7,144 | 56,514 | 22,841,809 | 22.8 M to 22.8 M (+0.03 %) |
Jun 14 2019 | UROV | Urovant Sciences L ... | QVT Associates GP LLC | 10% Owner | Buy | P | 7.95 | 7,367 | 58,543 | 22,834,665 | 22.8 M to 22.8 M (+0.03 %) |
Jun 14 2019 | UROV | Urovant Sciences L ... | QVT Associates GP LLC | 10% Owner | Buy | P | 8.30 | 7,500 | 62,244 | 22,827,298 | 22.8 M to 22.8 M (+0.03 %) |
Jun 11 2019 | UROV | Urovant Sciences L ... | QVT Associates GP LLC | 10% Owner | Buy | P | 8.58 | 7,189 | 61,694 | 22,819,798 | 22.8 M to 22.8 M (+0.03 %) |
Jun 11 2019 | UROV | Urovant Sciences L ... | QVT Associates GP LLC | 10% Owner | Buy | P | 8.35 | 7,500 | 62,594 | 22,812,609 | 22.8 M to 22.8 M (+0.03 %) |
Jun 11 2019 | UROV | Urovant Sciences L ... | QVT Associates GP LLC | 10% Owner | Buy | P | 7.97 | 6,649 | 52,959 | 22,805,109 | 22.8 M to 22.8 M (+0.03 %) |
Jun 06 2019 | MYOV | Myovant Sciences L ... | QVT Associates GP LLC | 10% Owner | Buy | P | 8.25 | 2,424,242 | 19,999,997 | 40,765,599 | 38.3 M to 40.8 M (+6.32 %) |
Jun 06 2019 | UROV | Urovant Sciences L ... | QVT Associates GP LLC | 10% Owner | Buy | P | 8.00 | 7,082 | 56,621 | 22,798,460 | 22.8 M to 22.8 M (+0.03 %) |
Jun 06 2019 | UROV | Urovant Sciences L ... | QVT Associates GP LLC | 10% Owner | Buy | P | 8.02 | 6,540 | 52,418 | 22,791,378 | 22.8 M to 22.8 M (+0.03 %) |
Jun 06 2019 | UROV | Urovant Sciences L ... | QVT Associates GP LLC | 10% Owner | Buy | P | 7.59 | 7,500 | 56,911 | 22,784,838 | 22.8 M to 22.8 M (+0.03 %) |
Jun 03 2019 | UROV | Urovant Sciences L ... | QVT Associates GP LLC | 10% Owner | Buy | P | 7.71 | 5,424 | 41,815 | 22,777,338 | 22.8 M to 22.8 M (+0.02 %) |
Jun 03 2019 | UROV | Urovant Sciences L ... | QVT Associates GP LLC | 10% Owner | Buy | P | 7.70 | 5,071 | 39,042 | 22,771,914 | 22.8 M to 22.8 M (+0.02 %) |
Jun 03 2019 | UROV | Urovant Sciences L ... | QVT Associates GP LLC | 10% Owner | Buy | P | 8.91 | 300 | 2,672 | 22,766,843 | 22.8 M to 22.8 M (0.00 %) |
Jun 03 2019 | UROV | Urovant Sciences L ... | QVT Associates GP LLC | 10% Owner | Buy | P | 7.97 | 6,951 | 55,418 | 22,766,543 | 22.8 M to 22.8 M (+0.03 %) |
May 29 2019 | UROV | Urovant Sciences L ... | QVT Associates GP LLC | 10% Owner | Buy | P | 7.55 | 6,882 | 51,983 | 22,759,592 | 22.8 M to 22.8 M (+0.03 %) |
May 29 2019 | UROV | Urovant Sciences L ... | QVT Associates GP LLC | 10% Owner | Buy | P | 7.68 | 3,807 | 29,245 | 22,752,710 | 22.7 M to 22.8 M (+0.02 %) |
May 29 2019 | UROV | Urovant Sciences L ... | QVT Associates GP LLC | 10% Owner | Buy | P | 7.70 | 3,796 | 29,233 | 22,748,903 | 22.7 M to 22.7 M (+0.02 %) |
May 23 2019 | UROV | Urovant Sciences L ... | QVT Associates GP LLC | 10% Owner | Buy | P | 7.76 | 4,802 | 37,252 | 22,745,107 | 22.7 M to 22.7 M (+0.02 %) |
May 23 2019 | UROV | Urovant Sciences L ... | QVT Associates GP LLC | 10% Owner | Buy | P | 8.06 | 5,033 | 40,558 | 22,740,305 | 22.7 M to 22.7 M (+0.02 %) |
May 23 2019 | UROV | Urovant Sciences L ... | QVT Associates GP LLC | 10% Owner | Buy | P | 8.52 | 9,995 | 85,108 | 22,735,272 | 22.7 M to 22.7 M (+0.04 %) |
May 20 2019 | UROV | Urovant Sciences L ... | QVT Associates GP LLC | 10% Owner | Buy | P | 8.39 | 1,715 | 14,383 | 22,725,277 | 22.7 M to 22.7 M (+0.01 %) |
May 20 2019 | UROV | Urovant Sciences L ... | QVT Associates GP LLC | 10% Owner | Buy | P | 7.98 | 8,285 | 66,142 | 22,723,562 | 22.7 M to 22.7 M (+0.04 %) |
May 20 2019 | UROV | Urovant Sciences L ... | QVT Associates GP LLC | 10% Owner | Buy | P | 7.36 | 6,200 | 45,641 | 22,715,277 | 22.7 M to 22.7 M (+0.03 %) |
May 20 2019 | UROV | Urovant Sciences L ... | QVT Associates GP LLC | 10% Owner | Buy | P | 6.79 | 5,408 | 36,718 | 22,709,077 | 22.7 M to 22.7 M (+0.02 %) |
Mar 19 2019 | AXON | Axovant Sciences L ... | QVT Associates GP LLC | 10% Owner | Buy | P | 1.50 | 6,666,667 | 10,000,001 | 105,952,381 | 99.3 M to 106 M (+6.71 %) |
Dec 20 2018 | AXON | Axovant Sciences L ... | QVT Associates GP LLC | 10% Owner | Buy | P | 1.00 | 10,000,000 | 10,000,000 | 99,285,714 | 89.3 M to 99.3 M (+11.20 %) |
Oct 03 2018 | UROV | Urovant Sciences L ... | QVT Associates GP LLC | 10% Owner | Buy | P | 14.00 | 2,678,571 | 37,499,994 | 22,703,669 | 20 M to 22.7 M (+13.38 %) |
Jun 07 2018 | AXON | Axovant Sciences L ... | QVT Associates GP LLC | 10% Owner | Buy | P | 1.75 | 14,285,714 | 25,000,000 | 89,285,714 | 75 M to 89.3 M (+19.05 %) |
Apr 04 2018 | MYOV | Myovant Sciences L ... | QVT Associates GP LLC | Director | Buy | P | 20.27 | 1,110,015 | 22,500,004 | 38,341,357 | 37.2 M to 38.3 M (+2.98 %) |
Jan 16 2018 | TKMR | Arbutus Biopharma ... | QVT Associates GP LLC | Director | Option Exercise | P | 7.13 | 664,000 | 4,734,320 | 1,164,000 | |
Oct 17 2017 | TKMR | Arbutus Biopharma ... | QVT Associates GP LLC | Director | Option Exercise | P | 7.13 | 500,000 | 3,565,000 | 500,000 | |
Dec 27 2013 | ACHN | ACHILLION PHARMACE ... | QVT Associates GP LLC | 10% Owner | Sell | S | 3.46 | 50,000 | 173,000 | 10,987,192 | 11 M to 11 M (-0.45 %) |
Dec 27 2013 | ACHN | ACHILLION PHARMACE ... | QVT Associates GP LLC | 10% Owner | Sell | S | 3.41 | 30,992 | 105,683 | 11,037,192 | 11.1 M to 11 M (-0.28 %) |
Dec 27 2013 | ACHN | ACHILLION PHARMACE ... | QVT Associates GP LLC | 10% Owner | Sell | S | 3.43 | 40,213 | 137,931 | 11,068,184 | 11.1 M to 11.1 M (-0.36 %) |
Dec 24 2013 | ACHN | ACHILLION PHARMACE ... | QVT Associates GP LLC | 10% Owner | Sell | S | 3.37 | 31,986 | 107,793 | 11,108,397 | 11.1 M to 11.1 M (-0.29 %) |
Dec 24 2013 | ACHN | ACHILLION PHARMACE ... | QVT Associates GP LLC | 10% Owner | Sell | S | 3.30 | 75,000 | 247,500 | 11,140,383 | 11.2 M to 11.1 M (-0.67 %) |
Dec 24 2013 | ACHN | ACHILLION PHARMACE ... | QVT Associates GP LLC | 10% Owner | Sell | S | 3.25 | 75,000 | 243,750 | 11,215,383 | 11.3 M to 11.2 M (-0.66 %) |
Dec 24 2013 | ACHN | ACHILLION PHARMACE ... | QVT Associates GP LLC | 10% Owner | Sell | S | 3.16 | 75,000 | 237,000 | 11,290,383 | 11.4 M to 11.3 M (-0.66 %) |
Dec 24 2013 | ACHN | ACHILLION PHARMACE ... | QVT Associates GP LLC | 10% Owner | Sell | S | 3.16 | 32,155 | 101,610 | 11,365,383 | 11.4 M to 11.4 M (-0.28 %) |
Dec 20 2013 | ACHN | ACHILLION PHARMACE ... | QVT Associates GP LLC | 10% Owner | Sell | S | 3.15 | 32,800 | 103,320 | 11,397,538 | 11.4 M to 11.4 M (-0.29 %) |
Dec 20 2013 | ACHN | ACHILLION PHARMACE ... | QVT Associates GP LLC | 10% Owner | Sell | S | 3.09 | 100,000 | 309,000 | 11,430,338 | 11.5 M to 11.4 M (-0.87 %) |
Dec 20 2013 | ACHN | ACHILLION PHARMACE ... | QVT Associates GP LLC | 10% Owner | Sell | S | 3.06 | 89,812 | 274,825 | 11,530,338 | 11.6 M to 11.5 M (-0.77 %) |
Dec 18 2013 | ACHN | ACHILLION PHARMACE ... | QVT Associates GP LLC | 10% Owner | Sell | S | 3.08 | 42,156 | 129,840 | 11,620,150 | 11.7 M to 11.6 M (-0.36 %) |
Dec 18 2013 | ACHN | ACHILLION PHARMACE ... | QVT Associates GP LLC | 10% Owner | Sell | S | 3.13 | 50,647 | 158,525 | 11,662,306 | 11.7 M to 11.7 M (-0.43 %) |
Oct 02 2013 | ACHN | ACHILLION PHARMACE ... | QVT Associates GP LLC | 10% Owner | Sell | S | 3.27 | 250,000 | 817,500 | 11,712,953 | 12 M to 11.7 M (-2.09 %) |
Oct 02 2013 | ACHN | ACHILLION PHARMACE ... | QVT Associates GP LLC | 10% Owner | Sell | S | 3.50 | 2,250,000 | 7,875,000 | 11,962,953 | 14.2 M to 12 M (-15.83 %) |
Oct 02 2013 | ACHN | ACHILLION PHARMACE ... | QVT Associates GP LLC | 10% Owner | Sell | S | 3.43 | 254,900 | 874,307 | 14,212,953 | 14.5 M to 14.2 M (-1.76 %) |
Aug 12 2013 | ACHN | ACHILLION PHARMACE ... | QVT Associates GP LLC | 10% Owner | Buy | P | 6.37 | 65,982 | 420,305 | 14,467,853 | 14.4 M to 14.5 M (+0.46 %) |
Aug 12 2013 | ACHN | ACHILLION PHARMACE ... | QVT Associates GP LLC | 10% Owner | Buy | P | 6.48 | 36,300 | 235,224 | 14,401,871 | 14.4 M to 14.4 M (+0.25 %) |
Jul 15 2013 | ACHN | ACHILLION PHARMACE ... | QVT Associates GP LLC | 10% Owner | Buy | P | 6.47 | 59,662 | 386,013 | 14,365,571 | 14.3 M to 14.4 M (+0.42 %) |
Jul 15 2013 | ACHN | ACHILLION PHARMACE ... | QVT Associates GP LLC | 10% Owner | Buy | P | 6.46 | 341,355 | 2,205,153 | 14,305,909 | 14 M to 14.3 M (+2.44 %) |
Jul 11 2013 | ACHN | ACHILLION PHARMACE ... | QVT Associates GP LLC | 10% Owner | Buy | P | 6.38 | 90,944 | 580,223 | 13,964,554 | 13.9 M to 14 M (+0.66 %) |
Jul 11 2013 | ACHN | ACHILLION PHARMACE ... | QVT Associates GP LLC | 10% Owner | Buy | P | 6.35 | 100,000 | 635,000 | 13,873,610 | 13.8 M to 13.9 M (+0.73 %) |
Jul 11 2013 | ACHN | ACHILLION PHARMACE ... | QVT Associates GP LLC | 10% Owner | Buy | P | 6.30 | 200,000 | 1,260,000 | 13,773,610 | 13.6 M to 13.8 M (+1.47 %) |
Jul 09 2013 | ACHN | ACHILLION PHARMACE ... | QVT Associates GP LLC | 10% Owner | Buy | P | 6.30 | 445,209 | 2,804,817 | 13,573,610 | 13.1 M to 13.6 M (+3.39 %) |
Jul 09 2013 | ACHN | ACHILLION PHARMACE ... | QVT Associates GP LLC | 10% Owner | Buy | P | 6.21 | 72,300 | 448,983 | 13,128,401 | 13.1 M to 13.1 M (+0.55 %) |
Jul 09 2013 | ACHN | ACHILLION PHARMACE ... | QVT Associates GP LLC | 10% Owner | Buy | P | 6.26 | 125,000 | 782,500 | 13,056,101 | 12.9 M to 13.1 M (+0.97 %) |
Jul 05 2013 | ACHN | ACHILLION PHARMACE ... | QVT Associates GP LLC | 10% Owner | Buy | P | 6.24 | 442,737 | 2,762,679 | 12,931,101 | 12.5 M to 12.9 M (+3.55 %) |
Jul 05 2013 | ACHN | ACHILLION PHARMACE ... | QVT Associates GP LLC | 10% Owner | Buy | P | 6.32 | 20,511 | 129,630 | 12,488,364 | 12.5 M to 12.5 M (+0.16 %) |
Jul 05 2013 | ACHN | ACHILLION PHARMACE ... | QVT Associates GP LLC | 10% Owner | Buy | P | 6.51 | 1,300,000 | 8,463,000 | 12,467,853 | 11.2 M to 12.5 M (+11.64 %) |
Jul 05 2013 | ACHN | ACHILLION PHARMACE ... | QVT Associates GP LLC | 10% Owner | Buy | P | 6.30 | 150,000 | 945,000 | 11,167,853 | 11 M to 11.2 M (+1.36 %) |
Jul 05 2013 | ACHN | ACHILLION PHARMACE ... | QVT Associates GP LLC | 10% Owner | Buy | P | 6.31 | 50,000 | 315,500 | 11,017,853 | 11 M to 11 M (+0.46 %) |
Oct 24 2011 | ANDS | ANADYS PHARMACEUTI ... | QVT Associates GP LLC | 10% Owner | Sell | S | 3.68 | 364,918 | 1,342,898 | 5,152,936 | 5.5 M to 5.2 M (-6.61 %) |
Oct 24 2011 | ANDS | ANADYS PHARMACEUTI ... | QVT Associates GP LLC | 10% Owner | Sell | S | 3.68 | 5,252,700 | 19,329,936 | 5,517,854 | 10.8 M to 5.5 M (-48.77 %) |
Oct 19 2011 | ANDS | ANADYS PHARMACEUTI ... | QVT Associates GP LLC | 10% Owner | Sell | S | 3.68 | 650,100 | 2,392,368 | 10,770,554 | 11.4 M to 10.8 M (-5.69 %) |
Sep 28 2011 | INHX | INHIBITEX, INC. | QVT Associates GP LLC | 10% Owner | Sell | S | 3.00 | 200,000 | 600,000 | 7,700,662 | 7.9 M to 7.7 M (-2.53 %) |
Sep 28 2011 | INHX | INHIBITEX, INC. | QVT Associates GP LLC | 10% Owner | Sell | S | 3.01 | 2,500 | 7,525 | 7,900,662 | 7.9 M to 7.9 M (-0.03 %) |
Sep 28 2011 | INHX | INHIBITEX, INC. | QVT Associates GP LLC | 10% Owner | Sell | S | 3.10 | 1,400 | 4,340 | 7,903,162 | 7.9 M to 7.9 M (-0.02 %) |
Sep 28 2011 | INHX | INHIBITEX, INC. | QVT Associates GP LLC | 10% Owner | Sell | S | 2.97 | 30,000 | 89,100 | 7,904,562 | 7.9 M to 7.9 M (-0.38 %) |
Jun 09 2011 | MDVN | MEDIVATION, INC. | QVT Associates GP LLC | 10% Owner | Sell | S | 22.52 | 60,055 | 1,352,439 | 3,331,729 | 3.4 M to 3.3 M (-1.77 %) |
Jun 09 2011 | MDVN | MEDIVATION, INC. | QVT Associates GP LLC | 10% Owner | Sell | S | 22.71 | 1,209 | 27,456 | 3,391,784 | 3.4 M to 3.4 M (-0.04 %) |
Jun 09 2011 | MDVN | MEDIVATION, INC. | QVT Associates GP LLC | 10% Owner | Sell | S | 22.58 | 202,798 | 4,579,179 | 3,392,993 | 3.6 M to 3.4 M (-5.64 %) |
Jun 09 2011 | MDVN | MEDIVATION, INC. | QVT Associates GP LLC | 10% Owner | Sell | S | 22.77 | 104,085 | 2,370,015 | 3,595,791 | 3.7 M to 3.6 M (-2.81 %) |
Jun 06 2011 | MDVN | MEDIVATION, INC. | QVT Associates GP LLC | 10% Owner | Sell | S | 22.15 | 6,306 | 139,678 | 3,699,876 | 3.7 M to 3.7 M (-0.17 %) |
Jun 06 2011 | MDVN | MEDIVATION, INC. | QVT Associates GP LLC | 10% Owner | Sell | S | 21.91 | 67,151 | 1,471,278 | 3,706,182 | 3.8 M to 3.7 M (-1.78 %) |
Jun 06 2011 | MDVN | MEDIVATION, INC. | QVT Associates GP LLC | 10% Owner | Sell | S | 22.58 | 54,377 | 1,227,833 | 3,773,333 | 3.8 M to 3.8 M (-1.42 %) |
Jun 06 2011 | MDVN | MEDIVATION, INC. | QVT Associates GP LLC | 10% Owner | Sell | S | 22.56 | 10,578 | 238,640 | 3,827,710 | 3.8 M to 3.8 M (-0.28 %) |
Jun 06 2011 | MDVN | MEDIVATION, INC. | QVT Associates GP LLC | 10% Owner | Sell | S | 22.70 | 79,591 | 1,806,716 | 3,838,288 | 3.9 M to 3.8 M (-2.03 %) |
Jun 06 2011 | MDVN | MEDIVATION, INC. | QVT Associates GP LLC | 10% Owner | Sell | S | 22.85 | 25,652 | 586,148 | 3,917,879 | 3.9 M to 3.9 M (-0.65 %) |
Jun 06 2011 | MDVN | MEDIVATION, INC. | QVT Associates GP LLC | 10% Owner | Sell | S | 22.82 | 25,100 | 572,782 | 3,943,531 | 4 M to 3.9 M (-0.63 %) |
Jun 02 2011 | INHX | INHIBITEX, INC. | QVT Associates GP LLC | 10% Owner | Sell | S | 4.58 | 55,000 | 251,900 | 7,934,562 | 8 M to 7.9 M (-0.69 %) |
Jun 02 2011 | INHX | INHIBITEX, INC. | QVT Associates GP LLC | 10% Owner | Sell | S | 4.49 | 600,000 | 2,694,000 | 7,989,562 | 8.6 M to 8 M (-6.99 %) |
Apr 11 2011 | INHX | INHIBITEX, INC. | QVT Associates GP LLC | 10% Owner | Sell | S | 4.29 | 78,335 | 336,057 | 8,589,562 | 8.7 M to 8.6 M (-0.90 %) |
Apr 11 2011 | INHX | INHIBITEX, INC. | QVT Associates GP LLC | 10% Owner | Sell | S | 4.28 | 60,717 | 259,869 | 8,667,897 | 8.7 M to 8.7 M (-0.70 %) |
Apr 11 2011 | INHX | INHIBITEX, INC. | QVT Associates GP LLC | 10% Owner | Sell | S | 4.39 | 105,382 | 462,627 | 8,728,614 | 8.8 M to 8.7 M (-1.19 %) |
Apr 11 2011 | INHX | INHIBITEX, INC. | QVT Associates GP LLC | 10% Owner | Sell | S | 4.37 | 230,000 | 1,005,100 | 8,833,996 | 9.1 M to 8.8 M (-2.54 %) |
Apr 11 2011 | INHX | INHIBITEX, INC. | QVT Associates GP LLC | 10% Owner | Sell | S | 4.52 | 129,757 | 586,502 | 9,063,996 | 9.2 M to 9.1 M (-1.41 %) |
Jan 04 2011 | TXPI | TPC Group Inc. | QVT Associates GP LLC | 10% Owner | Sell | S | 30.77 | 14,000 | 430,780 | 2,705,145 | 2.7 M to 2.7 M (-0.51 %) |
Jan 05 2011 | ANDS | ANADYS PHARMACEUTI ... | QVT Associates GP LLC | 10% Owner | Buy | P | 1.41 | 34,209 | 48,235 | 11,420,654 | 11.4 M to 11.4 M (+0.30 %) |
Jan 03 2011 | ANDS | ANADYS PHARMACEUTI ... | QVT Associates GP LLC | 10% Owner | Buy | P | 1.48 | 300 | 444 | 11,386,445 | 11.4 M to 11.4 M (0.00 %) |
Jan 03 2011 | ANDS | ANADYS PHARMACEUTI ... | QVT Associates GP LLC | 10% Owner | Buy | P | 1.45 | 267,014 | 387,170 | 11,386,145 | 11.1 M to 11.4 M (+2.40 %) |
Jan 03 2011 | ANDS | ANADYS PHARMACEUTI ... | QVT Associates GP LLC | 10% Owner | Buy | P | 1.46 | 50,000 | 73,000 | 11,119,131 | 11.1 M to 11.1 M (+0.45 %) |
Dec 29 2010 | TXPI | TPC Group Inc. | QVT Associates GP LLC | 10% Owner | Sell | S | 30.78 | 24,600 | 757,188 | 2,719,145 | 2.7 M to 2.7 M (-0.90 %) |
Dec 29 2010 | TXPI | TPC Group Inc. | QVT Associates GP LLC | 10% Owner | Sell | S | 30.85 | 49,000 | 1,511,650 | 2,743,745 | 2.8 M to 2.7 M (-1.75 %) |
Dec 01 2010 | MDVN | MEDIVATION, INC. | QVT Associates GP LLC | 10% Owner | Buy | P | 11.00 | 200 | 2,200 | 3,968,631 | 4 M to 4 M (+0.01 %) |
Nov 26 2010 | MDVN | MEDIVATION, INC. | QVT Associates GP LLC | 10% Owner | Buy | P | 10.99 | 2,100 | 23,079 | 3,968,431 | 4 M to 4 M (+0.05 %) |
Nov 19 2010 | MDVN | MEDIVATION, INC. | QVT Associates GP LLC | 10% Owner | Buy | P | 11.00 | 400 | 4,400 | 3,966,331 | 4 M to 4 M (+0.01 %) |
Oct 28 2010 | MDVN | MEDIVATION, INC. | QVT Associates GP LLC | 10% Owner | Buy | P | 11.42 | 14,901 | 170,169 | 3,965,931 | 4 M to 4 M (+0.38 %) |
Oct 28 2010 | MDVN | MEDIVATION, INC. | QVT Associates GP LLC | 10% Owner | Buy | P | 11.44 | 40,914 | 468,056 | 3,951,030 | 3.9 M to 4 M (+1.05 %) |
Oct 26 2010 | MDVN | MEDIVATION, INC. | QVT Associates GP LLC | 10% Owner | Buy | P | 11.28 | 22,726 | 256,349 | 3,910,116 | 3.9 M to 3.9 M (+0.58 %) |
Oct 26 2010 | MDVN | MEDIVATION, INC. | QVT Associates GP LLC | 10% Owner | Buy | P | 11.23 | 46,000 | 516,580 | 3,887,390 | 3.8 M to 3.9 M (+1.20 %) |
Oct 26 2010 | MDVN | MEDIVATION, INC. | QVT Associates GP LLC | 10% Owner | Buy | P | 11.23 | 49,070 | 551,056 | 3,841,390 | 3.8 M to 3.8 M (+1.29 %) |
Oct 26 2010 | MDVN | MEDIVATION, INC. | QVT Associates GP LLC | 10% Owner | Buy | P | 11.40 | 39,400 | 449,160 | 3,792,320 | 3.8 M to 3.8 M (+1.05 %) |
Dec 29 2010 | ANDS | ANADYS PHARMACEUTI ... | QVT Associates GP LLC | 10% Owner | Buy | P | 1.44 | 532,490 | 766,786 | 11,069,131 | 10.5 M to 11.1 M (+5.05 %) |
Dec 29 2010 | ANDS | ANADYS PHARMACEUTI ... | QVT Associates GP LLC | 10% Owner | Buy | P | 1.34 | 12,200 | 16,348 | 10,536,641 | 10.5 M to 10.5 M (+0.12 %) |
Dec 29 2010 | ANDS | ANADYS PHARMACEUTI ... | QVT Associates GP LLC | 10% Owner | Buy | P | 1.30 | 1,714,210 | 2,228,473 | 10,524,441 | 8.8 M to 10.5 M (+19.46 %) |
Dec 27 2010 | ANDS | ANADYS PHARMACEUTI ... | QVT Associates GP LLC | 10% Owner | Buy | P | 1.21 | 285,790 | 345,806 | 8,810,231 | 8.5 M to 8.8 M (+3.35 %) |
Oct 22 2010 | ANDS | ANADYS PHARMACEUTI ... | QVT Associates GP LLC | 10% Owner | Buy | P | 1.65 | 150,000 | 247,500 | 8,524,441 | 8.4 M to 8.5 M (+1.79 %) |
Oct 19 2010 | ANDS | ANADYS PHARMACEUTI ... | QVT Associates GP LLC | 10% Owner | Buy | P | 1.65 | 150,000 | 247,500 | 8,374,441 | 8.2 M to 8.4 M (+1.82 %) |
Oct 19 2010 | ANDS | ANADYS PHARMACEUTI ... | QVT Associates GP LLC | 10% Owner | Buy | P | 1.66 | 85,000 | 141,100 | 8,224,441 | 8.1 M to 8.2 M (+1.04 %) |
Oct 19 2010 | ANDS | ANADYS PHARMACEUTI ... | QVT Associates GP LLC | 10% Owner | Buy | P | 1.67 | 25,000 | 41,750 | 8,139,441 | 8.1 M to 8.1 M (+0.31 %) |
Oct 19 2010 | ANDS | ANADYS PHARMACEUTI ... | QVT Associates GP LLC | 10% Owner | Buy | P | 1.68 | 90,000 | 151,200 | 8,114,441 | 8 M to 8.1 M (+1.12 %) |
Oct 19 2010 | ANDS | ANADYS PHARMACEUTI ... | QVT Associates GP LLC | 10% Owner | Buy | P | 1.80 | 1,951,389 | 3,512,500 | 8,024,441 | 6.1 M to 8 M (+32.13 %) |
Sep 20 2010 | MDVN | MEDIVATION, INC. | QVT Associates GP LLC | 10% Owner | Buy | P | 11.49 | 8,823 | 101,376 | 3,752,920 | 3.7 M to 3.8 M (+0.24 %) |
Sep 20 2010 | MDVN | MEDIVATION, INC. | QVT Associates GP LLC | 10% Owner | Buy | P | 11.48 | 13,400 | 153,832 | 3,744,097 | 3.7 M to 3.7 M (+0.36 %) |
Sep 20 2010 | MDVN | MEDIVATION, INC. | QVT Associates GP LLC | 10% Owner | Buy | P | 11.50 | 7,427 | 85,411 | 3,730,697 | 3.7 M to 3.7 M (+0.20 %) |
Sep 16 2010 | MDVN | MEDIVATION, INC. | QVT Associates GP LLC | 10% Owner | Buy | P | 11.47 | 18,315 | 210,073 | 3,723,270 | 3.7 M to 3.7 M (+0.49 %) |
Sep 16 2010 | MDVN | MEDIVATION, INC. | QVT Associates GP LLC | 10% Owner | Buy | P | 11.48 | 13,154 | 151,008 | 3,704,955 | 3.7 M to 3.7 M (+0.36 %) |
Sep 14 2010 | MDVN | MEDIVATION, INC. | QVT Associates GP LLC | 10% Owner | Buy | P | 11.50 | 3,400 | 39,100 | 3,691,801 | 3.7 M to 3.7 M (+0.09 %) |
Sep 14 2010 | MDVN | MEDIVATION, INC. | QVT Associates GP LLC | 10% Owner | Buy | P | 11.45 | 68,600 | 785,470 | 3,688,401 | 3.6 M to 3.7 M (+1.90 %) |
Sep 14 2010 | MDVN | MEDIVATION, INC. | QVT Associates GP LLC | 10% Owner | Buy | P | 11.44 | 109,685 | 1,254,796 | 3,619,801 | 3.5 M to 3.6 M (+3.12 %) |
Sep 14 2010 | ANDS | ANADYS PHARMACEUTI ... | QVT Associates GP LLC | 10% Owner | Buy | P | 1.80 | 25,000 | 45,000 | 6,065,052 | 6 M to 6.1 M (+0.41 %) |
Sep 20 2010 | ANDS | ANADYS PHARMACEUTI ... | QVT Associates GP LLC | 10% Owner | Buy | P | 1.78 | 8,000 | 14,240 | 6,073,052 | 6.1 M to 6.1 M (+0.13 %) |
Sep 03 2010 | ANDS | ANADYS PHARMACEUTI ... | QVT Associates GP LLC | 10% Owner | Buy | P | 1.74 | 25,000 | 43,500 | 6,040,052 | 6 M to 6 M (+0.42 %) |
Aug 31 2010 | ANDS | ANADYS PHARMACEUTI ... | QVT Associates GP LLC | 10% Owner | Buy | P | 1.77 | 25,000 | 44,250 | 6,015,052 | 6 M to 6 M (+0.42 %) |
Aug 31 2010 | ANDS | ANADYS PHARMACEUTI ... | QVT Associates GP LLC | 10% Owner | Buy | P | 1.75 | 6,000 | 10,500 | 5,990,052 | 6 M to 6 M (+0.10 %) |
Aug 27 2010 | ANDS | ANADYS PHARMACEUTI ... | QVT Associates GP LLC | 10% Owner | Buy | P | 1.75 | 15,700 | 27,475 | 5,984,052 | 6 M to 6 M (+0.26 %) |
Aug 27 2010 | ANDS | ANADYS PHARMACEUTI ... | QVT Associates GP LLC | 10% Owner | Buy | P | 1.70 | 17,400 | 29,580 | 5,968,352 | 6 M to 6 M (+0.29 %) |
Aug 25 2010 | ANDS | ANADYS PHARMACEUTI ... | QVT Associates GP LLC | 10% Owner | Buy | P | 1.73 | 34,900 | 60,377 | 5,950,952 | 5.9 M to 6 M (+0.59 %) |
Aug 25 2010 | ANDS | ANADYS PHARMACEUTI ... | QVT Associates GP LLC | 10% Owner | Buy | P | 1.79 | 27,000 | 48,330 | 5,916,052 | 5.9 M to 5.9 M (+0.46 %) |
Aug 23 2010 | ANDS | ANADYS PHARMACEUTI ... | QVT Associates GP LLC | 10% Owner | Buy | P | 1.77 | 4,000 | 7,080 | 5,889,052 | 5.9 M to 5.9 M (+0.07 %) |
Aug 23 2010 | ANDS | ANADYS PHARMACEUTI ... | QVT Associates GP LLC | 10% Owner | Buy | P | 1.79 | 16,000 | 28,640 | 5,885,052 | 5.9 M to 5.9 M (+0.27 %) |
Aug 18 2010 | ANDS | ANADYS PHARMACEUTI ... | QVT Associates GP LLC | 10% Owner | Buy | P | 1.80 | 5,000 | 9,000 | 5,869,052 | 5.9 M to 5.9 M (+0.09 %) |
Aug 18 2010 | ANDS | ANADYS PHARMACEUTI ... | QVT Associates GP LLC | 10% Owner | Buy | P | 1.86 | 35,000 | 65,100 | 5,864,052 | 5.8 M to 5.9 M (+0.60 %) |
Aug 16 2010 | ANDS | ANADYS PHARMACEUTI ... | QVT Associates GP LLC | 10% Owner | Buy | P | 1.94 | 32,500 | 63,050 | 5,829,052 | 5.8 M to 5.8 M (+0.56 %) |
Aug 05 2010 | ANDS | ANADYS PHARMACEUTI ... | QVT Associates GP LLC | 10% Owner | Buy | P | 1.99 | 50,400 | 100,296 | 5,796,552 | 5.7 M to 5.8 M (+0.88 %) |
Jul 08 2010 | ANDS | ANADYS PHARMACEUTI ... | QVT Associates GP LLC | 10% Owner | Buy | P | 1.98 | 30,000 | 59,400 | 5,746,152 | 5.7 M to 5.7 M (+0.52 %) |
Jul 06 2010 | ANDS | ANADYS PHARMACEUTI ... | QVT Associates GP LLC | 10% Owner | Buy | P | 1.94 | 56,800 | 110,192 | 5,716,152 | 5.7 M to 5.7 M (+1.00 %) |
Apr 08 2010 | TXPI | TPC Group Inc. | QVT Associates GP LLC | 10% Owner | Buy | P | 12.75 | 194,490 | 2,479,748 | 2,792,745 | 2.6 M to 2.8 M (+7.49 %) |
Dec 11 2009 | INHX | INHIBITEX, INC. | QVT Associates GP LLC | 10% Owner | Buy | P | 0.73 | 75,000 | 54,750 | 9,125,753 | 9.1 M to 9.1 M (+0.83 %) |
Dec 11 2009 | INHX | INHIBITEX, INC. | QVT Associates GP LLC | 10% Owner | Buy | P | 0.89 | 23,000 | 20,470 | 9,050,753 | 9 M to 9.1 M (+0.25 %) |
Dec 18 2009 | INHX | INHIBITEX, INC. | QVT Associates GP LLC | 10% Owner | Buy | P | 0.85 | 43,000 | 36,550 | 9,193,753 | 9.2 M to 9.2 M (+0.47 %) |
Dec 15 2009 | INHX | INHIBITEX, INC. | QVT Associates GP LLC | 10% Owner | Buy | P | 0.72 | 25,000 | 17,875 | 9,150,753 | 9.1 M to 9.2 M (+0.27 %) |
Dec 09 2009 | INHX | INHIBITEX, INC. | QVT Associates GP LLC | 10% Owner | Buy | P | 0.92 | 27,000 | 24,840 | 9,027,753 | 9 M to 9 M (+0.30 %) |
Dec 07 2009 | INHX | INHIBITEX, INC. | QVT Associates GP LLC | 10% Owner | Buy | P | 0.96 | 21,500 | 20,640 | 9,000,753 | 9 M to 9 M (+0.24 %) |
Dec 07 2009 | INHX | INHIBITEX, INC. | QVT Associates GP LLC | 10% Owner | Buy | P | 0.99 | 25,000 | 24,750 | 8,979,253 | 9 M to 9 M (+0.28 %) |
Dec 03 2009 | INHX | INHIBITEX, INC. | QVT Associates GP LLC | 10% Owner | Buy | P | 0.98 | 14,000 | 13,720 | 8,954,253 | 8.9 M to 9 M (+0.16 %) |